MEDA PHARMS FDA Approval NDA 012366

NDA 012366

MEDA PHARMS

FDA Drug Application

Application #012366

Documents

Label2008-11-07
Label2009-11-16
Label2013-02-01
Label2013-05-14
Letter2008-10-28
Letter2010-01-06
Letter2013-02-04
Letter2013-05-13

Application Sponsors

NDA 012366MEDA PHARMS

Marketing Status

Discontinued002

Application Products

002TABLET;ORAL325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**0SOMA COMPOUND W/ CODEINEASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE

FDA Submissions

TYPE 4; Type 4 - New CombinationORIG1AP1960-10-05STANDARD
LABELING; LabelingSUPPL6AP1974-07-19STANDARD
LABELING; LabelingSUPPL9AP1981-11-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1981-11-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1981-10-29STANDARD
LABELING; LabelingSUPPL13AP1982-02-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1983-04-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1983-04-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1983-04-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1983-07-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1984-02-23STANDARD
LABELING; LabelingSUPPL21AP1986-01-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1993-10-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1998-04-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP2001-06-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP2000-03-02STANDARD
LABELING; LabelingSUPPL31AP2008-10-23STANDARD
LABELING; LabelingSUPPL32AP2009-11-06STANDARD
LABELING; LabelingSUPPL33AP2013-01-31STANDARD
LABELING; LabelingSUPPL34AP2013-05-09STANDARD

Submissions Property Types

ORIG1Null0
SUPPL6Null0
SUPPL9Null0
SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL21Null0
SUPPL25Null0
SUPPL26Null0
SUPPL28Null0
SUPPL29Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL34Null0

CDER Filings

MEDA PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 12366
            [companyName] => MEDA PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"SOMA COMPOUND W\/ CODEINE","activeIngredients":"ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE","strength":"325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"05\/09\/2013","submission":"SUPPL-34","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/012366s034lbl.pdf\"}]","notes":""},{"actionDate":"01\/31\/2013","submission":"SUPPL-33","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/012366s033lbl.pdf\"}]","notes":""},{"actionDate":"11\/06\/2009","submission":"SUPPL-32","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/012366s032lbl.pdf\"}]","notes":""},{"actionDate":"10\/23\/2008","submission":"SUPPL-31","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/012366s031lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"SOMA COMPOUND W\/ CODEINE","submission":"ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE","actionType":"325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2013-05-09
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.